Fundraising FoxAnzu Partners — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Somerville, US
Roger Diebold(Executive Officer, Director)Samuel Shian(Director)
BoardDavid Seldin(Director)
Board seatJohn Ho· per SEC Form D · $2.6M raise · filed Jul 2019
Sofregen develops silk protein-based biomaterials and medical devices for soft tissue regeneration in aesthetic and surgical procedures.
BiotechHealthtechMedical DevicesNew MaterialsCambridge, US
Milan Kofol(Executive Officer)Doug Sheldon(Director)Anh Hoang(Executive Officer)Howard Weisman(Executive Officer, Director)
BoardAmir Nashat(Director)in
PartnerJenna Abelli· led
Co-investorsPolaris Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.